Dr. Pranav Garimella, CMO of the American Kidney Fund, discussed AMKD awareness and the importance of APOL1 gene variants. Dr. Daryl Crenshaw gave a detailed review of the significance of the APOL1 gene at the NephCure 2025 Patient Summit. A study examined the association of APOL1 risk variants and genotypes with chronic kidney disease among West Africans. There is a gap in knowledge regarding the baseline risk of kidney disease in healthy patients with two APOL1 gene variants.